How CBD Might Protect the Gut: Antioxidant and Anti-Inflammatory Pathways ↗
Review mapped CBD's gut-protective mechanisms: antioxidant pathway activation, anti-inflammatory signaling, barrier integrity preservation, and microbiota modulation.
Browse more cannabis research, findings, methods, and limitations.
Review mapped CBD's gut-protective mechanisms: antioxidant pathway activation, anti-inflammatory signaling, barrier integrity preservation, and microbiota modulation.
Pilot study tracking daily cannabis use motives over 28 days finds shifts toward sleep-aid and availability motives predict higher use, demonstrating feasibility of adaptive just-in-time interventions.
Large database study finds chronic pancreatitis patients with cannabis use disorder had 74% fewer pancreatic cancer detections but slightly more acute flare-ups, warranting further investigation.
THC directly blocks pain-signaling sodium channels NaV1.7 and NaV1.8 through the local anesthetic binding site, revealing a cannabinoid-receptor-independent mechanism for pain relief.
Chronic CBD reduced nerve pain in all rat anxiety lineages but had differential anxiety effects, with anxiety-prone animals responding less — suggesting individual anxiety traits may affect CBD treatment outcomes.
EEG study finds current cannabis users show heightened brain responses to cannabis cues and blunted monetary reward responses, but paradoxically, stronger cue reactions predicted reduced use at 3 months.
Network analysis reveals alcohol problems link uniquely to anxiety and suicidal thoughts while cannabis problems link to mania and dissociation, with patterns stable across ages 16-81.
AI analysis of Reddit identified 1,177 self-reported cannabis adverse experiences requiring medical attention, demonstrating social media's potential for cannabis product safety surveillance.
First pilot trial of H4 deep brain stimulation for cannabis use disorder found the treatment feasible and tolerable — laying groundwork for controlled efficacy trials.
New measurement approach captures 36 state cannabis policy characteristics across three bundles (pharmaceutical, permissive, fiscal), enabling research on how specific policy features affect health outcomes.
Genetically modified fruit fly with chronic pain-related sodium channel mutation responds to CBD but not conventional treatment, validating a fast, ethical model for screening new pain medications.
LGS diagnoses in the US jumped ~60% after the 2018 FDA approval of CBD for the condition, then returned to baseline, suggesting treatment availability may have influenced diagnostic practices.
Brain imaging shows cannabis use has opposite inflammation effects in healthy people (lower) versus psychosis patients (higher), and may block antipsychotic medication's brain effects in psychosis.
Review explores how the recently discovered mitochondrial CB1 receptor regulates brain energy, memory, and neuronal survival, with potential implications for treating neurodegenerative diseases.
CB1 receptor knockout mice show significantly lower preterm birth rates under inflammatory conditions, with reduced prostaglandins and inflammatory markers in uterine tissue.
Ten-year analysis of 2,256 youth entering residential care shows hazardous cannabis use increasing — especially among girls and older teens — diverging from declining trends in the general youth population.
Commentary reveals cannabis cognitive research is male-centered and underpowered for sex analysis, with only 6 of 29 studies finding sex differences — likely reflecting methods, not biology.
Cluster-randomized trial shows systematic cannabis screening in 19 primary care sites increased detection 17-fold and doubled treatment initiation for CUD, but treatment engagement remained unchanged.
Only 19% of older cannabis users discussed use with clinicians; Hispanic/Latine adults least likely to be screened.
Systematic review of 92 studies found even low THC doses can trigger positive urine tests, and regular users may test positive for weeks — exposing problems with current thresholds.
Meta-analysis: cannabis advertising linked to 77% higher odds of use; social media ads showed strongest effect (3.38x).
College students misusing stimulants had significantly higher cannabis use, especially nonmedical misusers.
Over a decade, the teen cannabis-distress link grew stronger, especially for frequent female users, while overall teen use declined.
Up to 95% of endometriosis patients use cannabis for pain, but no controlled trials exist to confirm efficacy.
Phase 2 RCT: CBD missed primary cardiac endpoints but significantly reduced LV mass and showed anti-inflammatory trends in myocarditis.
Among people with HIV, cannabis users motivated by medical or emotional reasons had higher polysubstance use than recreational users.
A 12-week RCT found varenicline reduced cannabis use in men with CUD but had no effect in women.
Survey of 1,089 Canadians found symptom relief and daily functioning matter most when considering medical cannabis for cancer.
A 12-week virtual group therapy program reduced cannabis use, cravings, depression, and anxiety with 68% retention.
A text-based mobile treatment for young adults with CUD reduced cannabis use at 6 months with equal effectiveness in rural and urban areas.
National survey finds bisexual women had the highest rates of polysubstance combinations involving cannabis and binge drinking.
Review confirms THC impairs driving for 4-5 hours, CBD does not impair driving, and alcohol plus cannabis amplifies the effect.
A controlled crossover trial found cannabis reduced alcohol consumption by 19-27% in heavy drinkers who also use cannabis.
Study of 9,065 college students in seven countries finds polysubstance users had more childhood adversity, impulsivity, and ruminative thinking.
Behavioral economics study finds cannabis demand decreases as driving becomes more imminent, and risk perception influences consumption levels.
Trauma patients who tested positive for THC on admission were 66% more likely to screen positive for post-traumatic stress symptoms.
Prospective French study finds recreational drug use, including cannabis, nearly tripled the risk of major cardiac events at one year post-hospitalization.
Ten-year European data from 40 EDs shows cannabis toxicity severity stayed stable despite increasing potency.
Systematic review of 38 studies finds integrated CBT works for CUD with co-occurring conditions, and AI tools can enhance contingency management.
Mouse study reveals endocannabinoid-metabolizing enzymes help colon tumors evade the immune system; blocking the pathway improved immunotherapy.
Non-psychoactive hemp seed extract slowed colorectal cancer cell growth by triggering metabolic stress; adding an autophagy inhibitor boosted the effect by 30%.
Matched analysis of 1,596 patients finds cannabis use disorder linked to 82% more postoperative pain and 48% more wound issues after panniculectomy.
Cannabis smoke extract caused placental cell damage beyond what THC alone produced, and blocking cannabinoid receptors did not prevent it.
Daily diary study finds young adults report better sleep quality on days they use alcohol and cannabis together versus alcohol-only or no-use days.
High-dose CBG impaired sustained attention in female rats but not males, contradicting marketing claims of cognitive enhancement.
Analysis of 1,160 top YouTube videos finds hip-hop/rap 13x more likely to show nicotine or cannabis, generating over 100 billion substance impressions.
Older adults had lower baseline endocannabinoid levels but showed larger increases after cannabis use than younger adults.
202 emergency presentations for synthetic cannabinoid MDMB-4en-PINACA: 81% unconscious, 30% seizures, 4 deaths, mostly homeless men.
Review finds cannabinoids modulate autophagy in oral tissues via mTOR/AMPK pathways, with potential for oral cancer and periodontal disease.
Meta-analysis of 46 studies finds cannabis use elevates both pro- and anti-inflammatory markers, suggesting immunomodulation rather than anti-inflammatory effects.